JPRN-UMIN000044380已完成未知
Assessment of community pharmacies' support for smoking cessation treatment in collaboration with medical institutions - Assessment of community pharmacies' support for smoking cessation treatment in collaboration with medical institutions
School of Pharmacy, Nihon University0 个研究点目标入组 70 人开始时间: 2021年6月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients in the hospital 2. Patients continuing smoking cessation treatment 3. Men and women under the age of 20 4. Patients who did not get their consent to participate in the study
研究者
相似试验
尚未招募
Unknown
Evaluation of efficacy of the community pharmacy intervention to optimize serum potassium levels in patients with chronic kidney diseasechronic kidney diseaseJPRN-UMIN000049814ational Hospital Organization Mie Chuo Medical Center40
招募中
不适用
Increasing Community Pharmacy Involvement in the Prevention of Cardiovascular Disease ProjectACTRN12609000705280Monash450
尚未招募
不适用
Evaluating the feasibility and acceptability of the MedsCheck Plus service amongst community pharmacists and home-dwelling people living with dementiaDementiaACTRN12622001172796niversity of New South Wales (UNSW)25
进行中（未招募）
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® [Paracetamol (500mg) and Pseudoephedrine (30mg)] on subjects with nasal congestion accompanied by headache in the setting of a common coldThe medical rationale = to investigate this combination drug in the symptomatic relief of common cold with nasal symptoms. The reduction of symptom severity may allow subjects receiving active medication to return to work or school earlier than those receiving placebo. To study the drug in it’s ‘natural environment’, community pharmacists will function as local investigators. They will include subjects with early (= 48 hours) cold symptoms of blocked nose with headache.EUCTR2006-000058-35-BEPfizer Consumer Healthcare Comm. VA/SCA
进行中（未招募）
不适用
A community pharmacy based investigation in the self-medication areaEfficacy and safety of Sinutab® (Paracetamol (500mg)/Pseudoephedrine (30mg)) on subjects with nasal congestion accompanied by headache and/or fever in the setting of a common coldMedical rationale= Investigation of combination drug Sinutab in symptomatic relief of common cold with nasal symptoms. Community pharmacists are considered as local investigators including subjects with early (= 48 hours) cold symptoms of blocked nose with headache and/or fever.EUCTR2004-001637-41-BEPfizer Consumer Healthcare cva/sca